At the end of the project a "tool box" for regenerative approaches should be established which includes a variation of biocompatible approved biomaterials (knowledge-based materials) and adult stem cell types, and analytical tools (MRI1 and PET2) which can be composed for the specific medical need. VascuBone will remove bottlenecks regarding determination of the cellular markers necessary for efficient quality control of MSC3 and EPC4 based therapies, the specification of optimal MSC subpopulation and age related adult stem cell ATMPs5 for bone regeneration. First important results to reach this overall aim of save and effective therapies are available and will be published here.
Abbreviations1) MRI: Magnetic Resonance Imaging
2) PET: Positron-Emission-Tomography
3) MSC: Mesenchymal Stem Cells
4) EPC: Endothelial Progenitor Cells
5) ATMP: Advanced Medicinal Therapy Products
|The research leading to these results has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement n°242175|